KYTX
Kyverna Therapeutics, Inc.
7.10$
-5.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 0.22 | 0.27 | 0.00 | 0.00 | 0.00 | |
| 0.02 | 0.04 | 0.00 | 0.06 | 0.04 | |
| 0.22 | 0.27 | 0.00 | -0.06 | -0.04 | |
| 1.00 | 1.10 | 0.07 | 2.93 | 3.02 | |
| 0.24 | 0.31 | 0.02 | 0.79 | 0.82 | |
| 1.24 | 1.41 | 0.09 | 3.66 | 3.84 | |
| -1.02 | -1.14 | -0.09 | -3.72 | -3.84 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| -1.02 | -1.12 | -0.09 | -3.33 | -3.64 | |
| 0.00 | 0.00 | 0.00 | -3.33 | – | |
| -1.02 | -1.12 | -0.09 | -3.33 | -3.64 | |
| -1.00 | -1.08 | -0.09 | -3.27 | -3.59 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.